Band 1p36 Abnormalities and t(1;17) in Ovarian Carcinoma

Thompson, Floyd H.; Taetle, Raymond; Trent, Jeffrey M.; Liu, Yun; Massey-Brown, Kathy; Scott, Katherine; Weinstein, Ronald S.; Emerson, Julia; Alberts, David S.; Nelson, Mark A.

doi:10.1016/s0165-4608(96)00307-x

Cited by 29 publications

(21 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results indicate that several chromosomal regions were non randomly involved in abnormalities. The patients did not all show the same stage of histological grade and there was no relationship between the complexity of chromosome constitution 40~79,XX, fra(1q11) (q32), fra(3p21), fra(5q31), fra(7q22), fra(9q34), fra(11q23), fra(14q24), fra(15q22), fra(17q21), del(12p13), dup(2p11-12), inv11(p15;q23), inv(21p13;q22) [2], t(19:22)(q13;p13), t(21;22)(p13;q13), 2p+ [2] E2 26 II 46;XX, chtb(2p13), chtb(5q31) [3], chtb(7q22), chtb(17q21) [7], del(7q34), del(11p15), fra(11q23), fra(Xq27), i(2p13), t(14;21)(q11;q11) E3 22 II 46;XX, chtb(5q31), del(11p15),(q23), fra(17q21) E4 57 I 46;XX,gap(1p36),(q32) [2],gap(3p21), gap(5q31) [4], fra(5q31) [2], fra(7q22), fra(14q32)…”

Section: Discussionmentioning

confidence: 93%

“…,(q22) [3], gap(15q15) [3], dup(5q22), der(7,17)(p ,p ), i(Xq), dm [13], ace, tr and qr [7] E7 79 III 38-92,XX, gap(1q32), gap(3p21) [3], fra(1)(q21),(q32) [4], fra(3p21), fra(5q31) [8], fra(9q34), fra(10q23), fra(12q13), fra(17q25), del(4p15), del(5p15) [3], del(21q22), 13p+ and cancer progression. Chromosomes 3, 5 and 1 were (sequenced according to their frequency) most frequently involved in structural abnormalities in both endometrial and ovarian cases.…”

Section: Discussionmentioning

confidence: 99%

“…Our cytogenetic findings provide strong evidence that multiple genetic lesions are associated with the development of endometrial cancers, and that deletions of 3p13, p21, p23, q21 and q25 may play a specific role in the pathogenesis of such cancers. Chromosomal abnormalities have been known to occur in malignant tumors for a long time [1][2][3][4][5]. This study adds little to the understanding of the field of ovarian cancer cytogenetics; the results for endometrial cancer are more novel and could be improved by analyses of more cases.…”

Section: Discussionmentioning

confidence: 99%

“…Chromosomal deletions in cancer cells are often found to contain tumor suppressor genes [7,8]. Structural rearrangements of chromosome arms 1p, 1q, 3p, 3q, 6q, 7p, 9q, 11p, 11q, 17q, 19p, and 19q were identified in ovarian tumors [1][2][3]5]. Taken together, these findings suggest that certain chromosomal abnormalities are important in the pathogenesis of ovarian and endometrial cancers.…”

mentioning

confidence: 97%

“…Most of these neoplasms are associated with chromosomal abnormalities and show a constellation of rearrangements such as translocations, deletions, and inversions [1][2][3][4][5]. However, understanding of the molecular genetic and cyto genetic changes associated with ovarian tumor development and disease progression has been limited because of the extreme complexity of the abnormalities [2].…”

mentioning

confidence: 99%

See 4 more Smart Citations

Chromosomal Abnormalities in Endometrial and Ovarian Carcinomas

Pazarbaşı

Kasap

Demırhan

et al. 2007

Balkan Journal of Medical Genetics

View full text Add to dashboard Cite

Development and progression of human malignancies involve multiple genetic changes including chromosomal instabilities such as translocations, deletions, and inversions. Chromosomal abnormalities were observed in 23 cases with ovarian and endometrial cancer by cytogenetic studies using a GTG (G bands by trypsin using Giemsa) banding technique. Specific chromosome bands were frequently involved, and were most frequent on chromosomes 1, 2, 3, 5, 12 and 17. Clonal alterations were observed at the cancer breakpoints, such as 1q21, 1q32, 3p21, 7q22, 11q23 in ovarian and 1p36, 1q32, 2p12, 3p21, 7q22, 9q34, 11p15, 11q23, 12q13, 14q11, 14q32, 16p13, 21q22 in endometrial cases. These findings provide evidence that multiple genetic lesions are associated with the patho genesis of endometrial and ovarian cancer.

show abstract

Section: Discussionmentioning

confidence: 93%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 97%

mentioning

confidence: 99%

See 3 more Smart Citations

Chromosomal Abnormalities in Endometrial and Ovarian Carcinomas

Pazarbaşı

Kasap

Demırhan

et al. 2007

Balkan Journal of Medical Genetics

View full text Add to dashboard Cite

show abstract

Chromosome abnormalities in ovarian adenocarcinoma: I. nonrandom chromosome abnormalities from 244 cases

Taetle

Aickin

Yang

et al. 1999

Genes Chromosom. Cancer

Self Cite

View full text Add to dashboard Cite

Cytogenetics provides important insights into the molecular pathogenesis of human cancers. Although extensive data exist on recurring cytogenetic abnormalities in hematologic cancers, data on individual solid tumor types remain limited. Previous studies of ovarian carcinoma indicated the presence of multiple, complex clonal chromosome abnormalities. Cytogenetics remains one of a few techniques capable of detecting these multiple, simultaneously occurring genetic abnormalities. We describe cytogenetic abnormalities from a series of 244 primary ovarian cancer specimens referred to a single institution. A total of 201/244 cases had fully characterized clonal chromosome abnormalities, of which 134 showed clonal chromosome breakpoints. We used a novel statistical technique to detect nonrandom chromosome breakpoints at the level of chromosome regions. Nonrandom occurrence of chromosome breakpoints was detected at regions 1p1*, 1q1*, 1p2*, 1q2*, 1p3*, 1q3, 3p1*, 1q4*, 6q1*, 6p2, 6q2, 7p1*, 7q1, 7p2*, 11p1*, 11q1, 11q2*, 12p1, 12q2*, 13p1, and 19q1. Simultaneous occurrence of multiple abnormalities was common. However, 120/134 cases had breakpoints at one or more of 13 commonly involved regions (*), suggesting a hierarchy of genetic abnormalities. Among clinical and tumor variables that predict patient survival, tumor grade was significantly associated with the presence of chromosome breakpoints. In additional studies, we show that nonrandom chromosome abnormalities are associated with impaired survival in ovarian cancer and that specific, nonrandomly involved chromosome regions retain significant effects on survival when analyses are controlled for important clinical variables. Additional specific chromosome abnormalities in this series are described, including chromosome gains and losses in near‐diploid cases and homogeneously staining regions. These results suggest that recurring, nonrandom chromosome abnormalities are important in the pathogenesis and/or progression of ovarian cancers, and target areas of the genome for molecular genetic studies. Genes Chromosomes Cancer 25:290–300, 1999. © 1999 Wiley‐Liss, Inc.

show abstract